Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ritalin LA Feasibility Study in Preschoolers with ADHD
NCT00257725Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Mar 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by New York State Psychiatric Institute. Primary endpoints: Swanson, Nolan, and Pelham Questionnaire at 5 weeks, Clinical Global Impressions-Severity at 5 weeks and 1 more. Started Mar 2005; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00257725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257725.